{"nctId":"NCT00498706","briefTitle":"Effectiveness of Telephone Versus Face-to-Face CBT in Treating People With Depression","startDateStruct":{"date":"2007-12"},"conditions":["Depression"],"count":325,"armGroups":[{"label":"Telephone-administered CBT","type":"EXPERIMENTAL","interventionNames":["Behavioral: Telephone-administered cognitive behavioral therapy (T-CBT)"]},{"label":"Face-to-face CBT","type":"ACTIVE_COMPARATOR","interventionNames":["Behavioral: Face-to-face administered CBT (FtF-CBT)"]}],"interventions":[{"name":"Telephone-administered cognitive behavioral therapy (T-CBT)","otherNames":[]},{"name":"Face-to-face administered CBT (FtF-CBT)","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Has a current diagnosis of major depressive disorder\n* Has a primary care physician at Northwestern University in Illinois, or one of a number of approved community clinics in Chicago.\n* Resides in Illinois\n* Has a telephone\n* Speaks and reads English\n\nExclusion Criteria:\n\n* Hearing, voice, or visual impairment\n* Meets criteria for dementia\n* Diagnosed with a psychotic disorder, bipolar disorder, dissociative disorder, current substance abuse, or other condition for which participation in a clinical trial of psychotherapy may be either inappropriate or dangerous\n* Currently receiving individual psychotherapy or planning to receive psychotherapy during the treatment phase of the study\n* Planning to be out of town or unavailable for treatment for 4 weeks or more during the scheduled treatment time\n* Recent history of suicide attempts or is severely suicidal\n* Initiated treatment with an antidepressant in the 2 months before study entry (antidepressant medication is not exclusionary)\n* Depression determined to be primarily of an organic etiology","healthyVolunteers":true,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Attrition (Number of Therapy Sessions Attended)","description":"Number of therapy sessions attended was collected. At the end of treatment, the total number of sessions attended by each patient was collected.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"15.4","spread":"4.4"},{"groupId":"OG001","value":"13.7","spread":"6.1"}]}]}]},{"type":"PRIMARY","title":"Number of Participants Who Dropped Out of Therapy","description":"Using the number of therapy sessions attended, we categorized patients into:\n\n1. those who discontinued treatment before session 18, and those who completed session 18.\n2. those who discontinued before Session 5, and those who continued.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"34","spread":null},{"groupId":"OG001","value":"53","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7","spread":null},{"groupId":"OG001","value":"21","spread":null}]}]}]},{"type":"SECONDARY","title":"Health-related Quality of Life (SF-36V), Patient Satisfaction (Satisfaction Index - Mental Health), and Therapeutic Alliance (Working Alliance Inventory - Short Form)","description":null,"classes":[]},{"type":"PRIMARY","title":"Patient Health Questionnaire (PHQ)-9","description":"Measures depression on a 9 - item scale. Scores range from 0-27, with 0 being no symptoms. A difference of 5 or more points on the PHQ-9 is considered a clinically meaningful response to treatment.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"16.76","spread":"4.7"},{"groupId":"OG001","value":"16.76","spread":"4.8"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"10.78","spread":null},{"groupId":"OG001","value":"10.09","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"9.05","spread":null},{"groupId":"OG001","value":"8.62","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.55","spread":null},{"groupId":"OG001","value":"7.77","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.65","spread":null},{"groupId":"OG001","value":"6.74","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7.59","spread":null},{"groupId":"OG001","value":"6.60","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.42","spread":null},{"groupId":"OG001","value":"6.30","spread":null}]}]}]},{"type":"PRIMARY","title":"Depression, as Assessed by Hamilton Depression Rating Scale(Ham-D)","description":"Ham-D indicates Hamilton Depression Rating Scale,range is 0 to 52. A score of 0 means the best outcome with no depression symptoms reported, and a score of 52 is the worse outcome with highest level of depression reported. A difference of 3 points on the Hamilton scale has been identified as clinically significant.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"22.83","spread":"4.6"},{"groupId":"OG001","value":"22.83","spread":"4.6"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"18.07","spread":null},{"groupId":"OG001","value":"17.86","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"15.62","spread":null},{"groupId":"OG001","value":"16.45","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"14.94","spread":null},{"groupId":"OG001","value":"14.18","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"13.58","spread":null},{"groupId":"OG001","value":"12.51","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"14.58","spread":null},{"groupId":"OG001","value":"12.33","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"15.06","spread":null},{"groupId":"OG001","value":"12.14","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":163},"commonTop":[]}}}